Your Health, We Care
Ibrutinib is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
Ibrutinib is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) with 17p deletion.
Ibrutinib is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).
Ibrutinib is indicated for the treatment of adult and pediatric patients age 1 year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
from FDA，2024.05
LuciusVersionofIbrutinib:DosageandAdministration,Indications,PrecautionsIndicationsAdult patients wi···【more】
Recommended：942025-18-12
Ibrutinib is an oral Bruton's tyrosine kinase (BTK) inhibitor that was first approved by the U.S. FDA in November 2013 for the treatment of mantle cell lymphoma (MCL). It has b···【more】
Article source：Lucius LaosRelease date：2026-03-12Recommended：44
Ibrutinib (Imbruvica) is an oral Bruton's tyrosine kinase (BTK) inhibitor used to treat chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), Waldenström's m···【more】
Article source：Lucius LaosRelease date：2026-03-12Recommended：40
Ibrutinib is a small molecule that acts as a potent, irreversible inhibitor of Bruton's tyrosine kinase. It is used to treat chronic lymphocytic leukemia, mantle cell lymphoma,···【more】
Article source：Lucius LaosRelease date：2026-03-12Recommended：45
Ibrutinib (Imbruvica) is a type of medication called a kinase inhibitor, used to treat several types of blood cancers, as well as a serious complication of allogeneic stem cell tra···【more】
Article source：Lucius LaosRelease date：2026-03-12Recommended：38
Ibrutinib for the treatment of Chronic Lymphatic Leukemia【more】
Article source：Lucius LaosRelease date：2026-01-05Recommended：68
LuciusVersionofIbrutinib:DosageandAdministration,Indications,PrecautionsIndicationsAdult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.Adult···【more】
Article source：Lucius LaosRelease date：2025-12-18Recommended：94
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
